Sertoli Cell Tumor Associated with Familial Adenomatous Polyposis: A Case Study
-
By
-
Chandra Kakarala
-
Katie Bussing
-
Reema Patel
-
Jessica Moss
-
Zin W. Myint
-
August 24, 2026
Clinical Scorecard: Sertoli Cell Tumor Associated with Familial Adenomatous Polyposis: A Case Study
At a Glance
| Category | Detail |
|---|
| Condition | Sertoli Cell Tumor |
| Key Mechanisms | Associated with germline APC mutations and Wnt pathway activation. |
| Target Population | Adults with familial adenomatous polyposis (FAP). |
| Care Setting | Oncology and surgical management. |
Key Highlights
- Sertoli cell tumors are rare, comprising 1% of all testicular tumors.
- The patient had a genetically confirmed APC mutation linked to FAP.
- Histopathological assessment revealed a Sertoli cell tumor without high-risk features.
- Adjuvant chemotherapy was initiated post-colectomy, with dose adjustments due to neuropathy.
- Imaging raised concerns for rectal cancer, leading to further treatment.
Guideline-Based Recommendations
Diagnosis
- Histopathological evaluation is essential for diagnosis of Sertoli cell tumors.
Management
- Radical orchiectomy is standard care when malignancy cannot be excluded.
Monitoring & Follow-up
- Regular imaging and tumor marker assessments are recommended post-treatment.
Risks
- Patients with FAP have a high risk of colorectal cancer and potential for extra-intestinal malignancies.
Patient & Prescribing Data
Adult male with familial adenomatous polyposis and testicular neoplasm.
Chemotherapy with capecitabine and oxaliplatin was well tolerated but required dose adjustment.
Clinical Best Practices
- Consider genetic counseling for patients with familial adenomatous polyposis.
- Monitor for extra-intestinal malignancies in patients with FAP.
Related Resources & Content
